The Liver Unit, Queen Elizabeth University Hospital Birmingham, Birmingham, UK.
Department of Surgery and Transplantation, Swiss HPB Centre, University Hospital Zurich, Zurich, Switzerland.
J Hepatol. 2018 Mar;68(3):456-464. doi: 10.1016/j.jhep.2017.10.034. Epub 2017 Nov 15.
BACKGROUND & AIMS: Primary non-function and ischaemic cholangiopathy are the most feared complications following donation-after-circulatory-death (DCD) liver transplantation. The aim of this study was to design a new score on risk assessment in liver-transplantation DCD based on donor-and-recipient parameters.
Using the UK national DCD database, a risk analysis was performed in adult recipients of DCD liver grafts in the UK between 2000 and 2015 (n = 1,153). A new risk score was calculated (UK DCD Risk Score) on the basis of a regression analysis. This is validated using the United Network for Organ Sharing database (n = 1,617) and our own DCD liver-transplant database (n = 315). Finally, the new score was compared with two other available prediction systems: the DCD risk scores from the University of California, Los Angeles and King's College Hospital, London.
The following seven strongest predictors of DCD graft survival were identified: functional donor warm ischaemia, cold ischaemia, recipient model for end-stage liver disease, recipient age, donor age, previous orthotopic liver transplantation, and donor body mass index. A combination of these risk factors (UK DCD risk model) stratified the best recipients in terms of graft survival in the entire UK DCD database, as well as in the United Network for Organ Sharing and in our own DCD population. Importantly, the UK DCD Risk Score significantly predicted graft loss caused by primary non-function or ischaemic cholangiopathy in the futile group (>10 score points). The new prediction model demonstrated a better C statistic of 0.79 compared to the two other available systems (0.71 and 0.64, respectively).
The UK DCD Risk Score is a reliable tool to detect high-risk and futile combinations of donor-and-recipient factors in DCD liver transplantation. It is simple to use and offers a great potential for making better decisions on which DCD graft should be rejected or may benefit from functional assessment and further optimization by machine perfusion.
In this study, we provide a new prediction model for graft loss in donation-after-circulatory-death (DCD) liver transplantation. Based on UK national data, the new UK DCD Risk Score involves the following seven clinically relevant risk factors: donor age, donor body mass index, functional donor warm ischaemia, cold storage, recipient age, recipient laboratory model for end-stage liver disease, and retransplantation. Three risk classes were defined: low risk (0-5 points), high risk (6-10 points), and futile (>10 points). This new model stratified best in terms of graft survival compared to other available models. Futile combinations (>10 points) achieved an only very limited 1- and 5-year graft survival of 37% and less than 20%, respectively. In contrast, an excellent graft survival has been shown in low-risk combinations (≤5 points). The new model is easy to calculate at the time of liver acceptance. It may help to decide which risk combination will benefit from additional graft treatment, or which DCD liver should be declined for a certain recipient.
在接受心跳停止后捐献(DCD)肝移植后,原发性无功能和缺血性胆管炎是最令人担忧的并发症。本研究旨在基于供体和受者参数设计一种新的 DCD 肝移植风险评估评分。
利用英国全国 DCD 数据库,对 2000 年至 2015 年间英国接受 DCD 肝移植的成人受者(n=1153)进行风险分析。根据回归分析计算出新的风险评分(英国 DCD 风险评分)。使用联合器官共享网络数据库(n=1617)和我们自己的 DCD 肝移植数据库(n=315)对其进行验证。最后,将新评分与其他两种可用的预测系统进行比较:加利福尼亚大学洛杉矶分校和伦敦国王学院医院的 DCD 风险评分。
确定了 7 个对 DCD 移植物存活最强的预测因素:供体热缺血功能、冷缺血、受体终末期肝病模型、受体年龄、供体年龄、既往原位肝移植和供体体重指数。这些危险因素的组合(英国 DCD 风险模型)在整个英国 DCD 数据库、联合器官共享网络和我们自己的 DCD 人群中对最佳受者的移植物存活进行了最佳分层。重要的是,英国 DCD 风险评分显著预测了无功能或缺血性胆管炎导致的无效移植组(>10 分)的移植物丢失。新的预测模型显示出更高的 C 统计量 0.79,优于其他两种可用系统(分别为 0.71 和 0.64)。
英国 DCD 风险评分是一种可靠的工具,可用于检测 DCD 肝移植中供体和受者因素的高危和无效组合。它使用简单,为拒绝哪些 DCD 移植物或可能受益于功能评估和进一步优化提供了更大的潜力。
在这项研究中,我们提供了一种新的用于预测 DCD 肝移植中移植物丢失的预测模型。基于英国的全国数据,新的英国 DCD 风险评分涉及以下七个临床相关的风险因素:供体年龄、供体体重指数、供体热缺血功能、冷储存、受体年龄、受体终末期肝病模型和再次移植。定义了三个风险等级:低风险(0-5 分)、高风险(6-10 分)和无效(>10 分)。与其他可用模型相比,该新模型在移植物存活率方面的分层最佳。无效组合(>10 分)的 1 年和 5 年移植物存活率仅分别为 37%和低于 20%。相比之下,低风险组合(≤5 分)的移植物存活率非常好。新模型在接受肝移植时易于计算。它可能有助于确定哪种风险组合将受益于额外的移植物治疗,或者哪个 DCD 肝应该因特定受者而被拒绝。